Topics
- Next Generation of Anti-infective Agents
- Next Generation of Antibiotics Targeting Gram -
- Next Generation of Anti-TB Drugs
- Anti-virulence Strategies
- Targeting Host-pathogen Interactions
- Feedback from Drug Hunters in Academia and Non-profit Organizations
- Neurodegenerative Diseases
- Small Molecules for Immunooncology or Autoimmunity
- Small Molecules Precision Drugs for Autoimmune Diseases
- Small Molecule for Immune-oncology
- New Avenues in Drug Discovery Chemistry
- New Synthetic Technologies in Drug Discovery Chemistry (Dearomatization, Continuous Flow chemistry, Electrochemistry/photoredox enabling last stage functionalizations or new chemical space)
- Covalent Inhibitors in Drug Discovery
- Cell Based Assay for Small Molecules (Covalent Screening, Chemoproteomics/ Chemical biology, CETSA,…)
- Beyond PROTACS (Glues and small-molecule degraders, LYTAC, RIBOTAC, DUBTAC, etc)
- New Molecular Landscapes in Drug Discovery
- Fragment-based Approaches
- Macrocycles (preferentially non-peptidic)
- DNA-encoded libraries
- Bioinspired Compounds
- Exotic or Neglected Atoms and Functional Groups (Si, P, B, Se, SF5, etc)
- Case studies in Selected Therapeutic Areas
- Late-Breaking Topics: First Disclosures of Clinical Candidates